Showing results (91-100 of 131) with videos related to
Sort By:
Pageof 14
Journal of Medicinal Chemistry|May 29, 2013
Interfacial cavity filling to optimize CD4-mimetic miniprotein interactions with HIV-1 surface glycoproteinLaurence Morellato-Castillo, Priyamvada Acharya, Olivier Combes, et al.Biomaterials|October 25, 2011
Electrospun cellulose acetate phthalate fibers for semen induced anti-HIV vaginal drug deliveryChaobo Huang, Stefaan J Soenen, Ellen van Gulck, et al.Trials|December 15, 2019
Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapyWesley de Jong, Joeri Aerts, Sabine Allard, et al.Scientific Reports|September 22, 2017
A longitudinal analysis of the vaginal microbiota and vaginal immune mediators in women from sub-Saharan AfricaVicky Jespers, Jordan Kyongo, Sarah Joseph, et al.Plos One|December 14, 2011
DC-SIGN increases the affinity of HIV-1 envelope glycoprotein interaction with CD4Karolin Hijazi, Yufei Wang, Carlo Scala, et al.Journal of Virology|April 6, 2007
Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donorsAmandeep K Dhillon, Helen Donners, Ralph Pantophlet, et al.Scientific Reports|October 5, 2016
Evolutionary Dynamics and Complicated Genetic Transmission Network Patterns of HIV-1 CRF01_AE among MSM in Shanghai, ChinaXiaoshan Li, Yile Xue, Yi Lin, et al.Antiviral Research|November 14, 2006
A dual chamber model of female cervical mucosa for the study of HIV transmission and for the evaluation of candidate HIV microbicidesYven Van Herrewege, Jo Michiels, Anouk Waeytens, et al.Bioorganic & Medicinal Chemistry|September 10, 2014
From human immunodeficiency virus non-nucleoside reverse transcriptase inhibitors to potent and selective antitrypanosomal compoundsMuthusamy Venkatraj, Kevin K Ariën, Jan Heeres, et al.Journal of Medicinal Chemistry|January 20, 2016
2,6-Di(arylamino)-3-fluoropyridine Derivatives as HIV Non-Nucleoside Reverse Transcriptase InhibitorsSergey Sergeyev, Ashok Kumar Yadav, Philippe Franck, et al.Pageof 14